<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>HIV &amp; AIDS</title>
            <link>https://medicalxpress.com/hiv-aids-news/</link>
            <language>en-us</language> 
            <description>Latest health news and information about HIV &amp; AIDS</description>

                            <item>
                    <title>HIV injections work better than tablets for young people, clinical trial finds</title>
                    <description>Young people living with HIV manage their condition better when their antiretroviral therapy is given by injections every eight weeks rather than daily tablets, according to results of a trial in Africa led by UCL (University College London) researchers.</description>
                    <link>https://medicalxpress.com/news/2026-09-hiv-tablets-young-people-clinical.html</link>
                    <category></category>
                    <pubDate>Thu, 17 Sep 2026 18:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news708781562</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/injections.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Teaching the immune system to control HIV</title>
                    <description>There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives. Results from a clinical trial led by Rockefeller, Imperial College London, and the University of Oxford (RIO) have offered a new strategy, suggesting that just one or two doses of broadly neutralizing antibodies (bNAbs) can suppress the virus long term, keeping it at undetectable levels for months and even years.</description>
                    <link>https://medicalxpress.com/news/2026-09-immune-hiv.html</link>
                    <category></category>
                    <pubDate>Thu, 17 Sep 2026 15:00:08 EDT</pubDate>
                    <guid isPermaLink="false">news708871262</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/hiv-4.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Fiji declares national HIV crisis</title>
                    <description>Fiji has declared a national HIV crisis as sexual transmission and illicit drug use help spread the virus, now infecting an estimated one in 60 adults in the Pacific nation.</description>
                    <link>https://medicalxpress.com/news/2026-09-fiji-declares-national-hiv-crisis.html</link>
                    <category></category>
                    <pubDate>Thu, 17 Sep 2026 04:05:06 EDT</pubDate>
                    <guid isPermaLink="false">news708836672</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/hiv-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>What are we dying from?</title>
                    <description>Cardiovascular diseases now account for a third of deaths in adults over 40 in a rural South African population.</description>
                    <link>https://medicalxpress.com/news/2026-09-dying.html</link>
                    <category></category>
                    <pubDate>Mon, 14 Sep 2026 09:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news708591722</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cardiovascular-disease-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cognitive decline in HIV associated with mitochondrial inefficiency, study finds</title>
                    <description>Hannah Stadtler knew whom she wanted to work with before even arriving at VCU.</description>
                    <link>https://medicalxpress.com/news/2026-09-cognitive-decline-hiv-mitochondrial-inefficiency.html</link>
                    <category></category>
                    <pubDate>Fri, 11 Sep 2026 13:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news708344761</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-photo-of-a-woman-sta-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New research offers avenue to explore relationship between Alzheimer&#039;s and HIV</title>
                    <description>UNMC researchers have published an article in Alzheimer&#039;s &amp; Dementia detailing the creation of an animal model that helps resolve questions about the relationship between HIV and Alzheimer&#039;s disease (AD).</description>
                    <link>https://medicalxpress.com/news/2026-09-avenue-explore-relationship-alzheimer-hiv.html</link>
                    <category></category>
                    <pubDate>Thu, 10 Sep 2026 07:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news708234601</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/alzheimers-disease-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cancer medication helps reduce SIV reservoir, increasing hope for HIV cure</title>
                    <description>Emory University researchers have provided the first proof of concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved cancer medication. Venetoclax effectively targets and blocks Bcl-2, a protein that not only regulates whether cells live or die but also promotes the survival of cancer cells. Similarly, Bcl-2 is a culprit in sustaining HIV cell reservoirs.</description>
                    <link>https://medicalxpress.com/news/2026-09-cancer-medication-siv-reservoir-hiv.html</link>
                    <category></category>
                    <pubDate>Thu, 03 Sep 2026 16:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news707652687</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cancer-medication-help.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How HIV affects the eyes of aging adults</title>
                    <description>Older adults with well-controlled HIV may have a higher prevalence of certain eye conditions, particularly dry eye, compared with similar adults without HIV, according to a new study led by a University of Colorado Anschutz Department of Ophthalmology faculty member.</description>
                    <link>https://medicalxpress.com/news/2026-09-hiv-affects-eyes-aging-adults.html</link>
                    <category></category>
                    <pubDate>Wed, 02 Sep 2026 17:00:07 EDT</pubDate>
                    <guid isPermaLink="false">news707586061</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/old-person-eyes.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Understanding the link between hepatitis C and HIV persistence</title>
                    <description>Naglaa Shoukry and Petronela Ancuta, researchers in the Immunopathology Research Theme at the Centre de recherche du CHUM (CRCHUM), are shedding new light on one of the greatest challenges in HIV research: understanding why the virus remains in the body despite treatment.</description>
                    <link>https://medicalxpress.com/news/2026-09-link-hepatitis-hiv-persistence.html</link>
                    <category></category>
                    <pubDate>Wed, 02 Sep 2026 08:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news707554099</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/understanding-the-link-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Most states provide minors autonomy to consent to STI/HIV services</title>
                    <description>New data on LawAtlas.org capture details of state laws that allow individuals younger than the legal &quot;age of majority&quot; to autonomously consent to general health care, HIV and STI services. This longitudinal dataset includes state statutes and regulations for the 50 U.S. states, the District of Columbia and Puerto Rico and captures changes in the law from May 31, 2022, through Dec. 31, 2024.</description>
                    <link>https://medicalxpress.com/news/2026-08-states-minors-autonomy-consent-stihiv.html</link>
                    <category></category>
                    <pubDate>Mon, 31 Aug 2026 19:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news707398864</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/law.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Anti-immigrant &#039;public charge&#039; policy may have contributed to rise in HIV among Hispanic ropulations</title>
                    <description>Following the Trump administration&#039;s 2018 announcement of changes to the public charge rule that would penalize immigrants for using public benefit programs, antisanctuary counties in the U.S. saw a 16.8% increase in HIV cases among Hispanic populations, compared with baseline counties.</description>
                    <link>https://medicalxpress.com/news/2026-08-anti-immigrant-policy-contributed-hiv.html</link>
                    <category></category>
                    <pubDate>Tue, 25 Aug 2026 14:20:04 EDT</pubDate>
                    <guid isPermaLink="false">news706883283</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/hiv-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Aging with HIV: Global report highlights the need to prepare health systems</title>
                    <description>The Lancet HIV Commission on Aging&#039;s 2026 report highlights how profoundly the global HIV epidemic is changing.</description>
                    <link>https://medicalxpress.com/news/2026-08-aging-hiv-global-highlights-health.html</link>
                    <category></category>
                    <pubDate>Mon, 24 Aug 2026 13:20:07 EDT</pubDate>
                    <guid isPermaLink="false">news706793942</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/hiv-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>TB preventive treatment for people with HIV shown effective in real-world settings</title>
                    <description>Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable disease.</description>
                    <link>https://medicalxpress.com/news/2026-08-tb-treatment-people-hiv-shown.html</link>
                    <category></category>
                    <pubDate>Tue, 18 Aug 2026 07:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news706250882</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/male-patient.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>The Medicines Patent Pool is improving access to essential medication where it&#039;s most needed</title>
                    <description>The Medicines Patent Pool (MPP) is a not-for-profit organization founded in 2010 with the support of the United Nations. Its mission is to improve access to essential medicines in low and middle-income countries (LMICs). It negotiates voluntary licenses with patent holders—typically pharmaceutical companies—before granting nonexclusive and geographically limited sublicenses to manufacturers in targeted countries, where the originator companies—that is, those that bring new medicinal products to market—typically are not active. This results in low or no royalty payments by sublicensees to patent holders, together with competition among multiple sublicensees in the targeted geographic markets, which helps reduce the price of medicines.</description>
                    <link>https://medicalxpress.com/news/2026-08-medicines-patent-pool-access-essential.html</link>
                    <category></category>
                    <pubDate>Mon, 17 Aug 2026 13:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news706186682</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/medication-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Can video games help personalize cognitive care for vulnerable groups?</title>
                    <description>A group of 50 participants from across the United States sat at their computers and logged in to a bespoke video game designed by Northeastern University researchers.</description>
                    <link>https://medicalxpress.com/news/2026-08-video-games-personalize-cognitive-vulnerable.html</link>
                    <category></category>
                    <pubDate>Sun, 16 Aug 2026 16:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news705927990</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/can-video-games-help-p.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>HIV-1 proviruses may drive chronic systemic inflammation</title>
                    <description>HIV (human immunodeficiency virus) is a virus that attacks the body&#039;s immune system and remains a major global health challenge because of persistent viral reservoirs, despite effective treatments. Key factors include around 40 million people living with HIV, 1 million new infections each year and permanent viral DNA integration into host cells. Some HIV proviruses hide quietly in cells and escape both medicines and the immune system, creating a permanent viral reservoir that prevents patients from being cured.</description>
                    <link>https://medicalxpress.com/news/2026-08-hiv-proviruses-chronic-inflammation.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 16:40:08 EDT</pubDate>
                    <guid isPermaLink="false">news705587822</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/hiv-1-proviruses-may-d.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Triple-dose regimen may permanently clear HIV in infected newborns</title>
                    <description>Every year, more than 120,000 newborns worldwide contract HIV, creating a global health burden that requires lifelong treatment for millions of people—assuming they have access and can afford it. New research led by Oregon Health &amp; Science University suggests another possibility: a one-time regimen of therapies given to newborns within three days of birth to permanently clear the virus. The research is published today in the journal Nature Microbiology.</description>
                    <link>https://medicalxpress.com/news/2026-08-triple-dose-regimen-permanently-hiv.html</link>
                    <category></category>
                    <pubDate>Mon, 10 Aug 2026 05:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news705246781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/newborn-4.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Q&amp;A: Medicare spending on clinical care for people aging with HIV projected to rise steeply over next decade</title>
                    <description>As more Americans with HIV live into older age, Medicare spending on their care is projected to rise dramatically from $10.9 billion in 2026 to $27.3 billion in 2035, with HIV medications accounting for nearly two-thirds of total costs.</description>
                    <link>https://medicalxpress.com/news/2026-08-qa-medicare-clinical-people-aging.html</link>
                    <category></category>
                    <pubDate>Fri, 07 Aug 2026 13:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news705325321</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/qa-medicare-spending-o.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Liver disease and HIV: Study reveals major gaps in liver fibrosis screening and offers a promising solution</title>
                    <description>Thanks to antiretroviral therapy and improved control of viral hepatitis (HBV and HCV), people living with HIV generally live longer and healthier lives. However, liver disease remains common in this population and is one of the leading causes of death.</description>
                    <link>https://medicalxpress.com/news/2026-08-liver-disease-hiv-reveals-major.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 10:20:02 EDT</pubDate>
                    <guid isPermaLink="false">news705228002</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/liver-disease-and-hiv.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why adults living with HIV are at high risk for diabetes</title>
                    <description>A new UC San Francisco study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.</description>
                    <link>https://medicalxpress.com/news/2026-08-adults-hiv-high-diabetes.html</link>
                    <category></category>
                    <pubDate>Thu, 06 Aug 2026 08:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news705215882</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/type-2-diabetes-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Once‑weekly HIV pill as effective as daily dose, research shows</title>
                    <description>Around 78% of people living with HIV take a daily pill to manage their infection. These drugs work by preventing HIV from multiplying.</description>
                    <link>https://medicalxpress.com/news/2026-08-onceweekly-hiv-pill-effective-daily.html</link>
                    <category></category>
                    <pubDate>Wed, 05 Aug 2026 12:40:07 EDT</pubDate>
                    <guid isPermaLink="false">news705151622</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/pill-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New model maps where HIV is concentrated and the disease is more advanced</title>
                    <description>A new biostatistical modeling approach has the potential to support health decisions by pinpointing where HIV is concentrated and where people living with HIV are showing signs of severe immune suppression or delayed treatment. Published in iScience, the study shows the potential of using existing health data to identify both where HIV burden is concentrated and where different forms of prevention, treatment and support may be needed.</description>
                    <link>https://medicalxpress.com/news/2026-08-hiv-disease-advanced.html</link>
                    <category></category>
                    <pubDate>Wed, 05 Aug 2026 12:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news705148262</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-model-maps-where-h.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tumor-like tissue environments could hold clues to curing HIV</title>
                    <description>The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new Northwestern University study.</description>
                    <link>https://medicalxpress.com/news/2026-08-tumor-tissue-environments-clues-hiv.html</link>
                    <category></category>
                    <pubDate>Wed, 05 Aug 2026 08:00:07 EDT</pubDate>
                    <guid isPermaLink="false">news705129482</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/hiv-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Doravirine works as well as dolutegravir to suppress HIV viral load, study finds</title>
                    <description>If you&#039;re a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the &quot;gold standard,&quot; dolutegravir (DTG). Now, another once-daily, three-drug regimen has been found to be as effective as DTG in suppressing HIV viral load.</description>
                    <link>https://medicalxpress.com/news/2026-08-doravirine-dolutegravir-suppress-hiv-viral.html</link>
                    <category></category>
                    <pubDate>Mon, 03 Aug 2026 12:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news704977021</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/study-finds-doravirine.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Risk of death 21% lower in patients with HIV-related fungal disease who were given combination drug treatment</title>
                    <description>In a clinical trial of adults with HIV-related cryptococcal disease, those treated with a two-drug combination had a 21% lower risk of dying than those treated with just one drug. This is according to City St George&#039;s research presented July 31 at the International AIDS Conference 2026 in Brazil.</description>
                    <link>https://medicalxpress.com/news/2026-08-death-patients-hiv-fungal-disease.html</link>
                    <category></category>
                    <pubDate>Mon, 03 Aug 2026 10:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news704965046</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/hiv-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response</title>
                    <description>Scientists at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in a nonhuman primate model of HIV/AIDS.</description>
                    <link>https://medicalxpress.com/news/2026-07-probiotic-derived-bioactive-metabolite-reverses.html</link>
                    <category></category>
                    <pubDate>Thu, 30 Jul 2026 18:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news704646164</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/probiotic-derived-bioa.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>International study shows once-weekly HIV pill performs as well as daily treatment</title>
                    <description>An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as current leading daily therapies, offering the potential for a new treatment option that could reduce the burden of lifelong daily pill-taking.</description>
                    <link>https://medicalxpress.com/news/2026-07-international-weekly-hiv-pill-daily.html</link>
                    <category></category>
                    <pubDate>Thu, 30 Jul 2026 10:40:10 EDT</pubDate>
                    <guid isPermaLink="false">news704625722</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/take-a-pill.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How US HIV funding cuts quickly affected care in East Africa</title>
                    <description>The U.S. government&#039;s withdrawal of funding for global HIV programs in January 2025 sharply reduced the number of people entering HIV care across East Africa within weeks, according to findings led by UC San Francisco researchers.</description>
                    <link>https://medicalxpress.com/news/2026-07-hiv-funding-quickly-affected-east.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Jul 2026 17:20:08 EDT</pubDate>
                    <guid isPermaLink="false">news704476921</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/tanzania.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Four-paper series broadens sex workers&#039; health focus beyond HIV prevention</title>
                    <description>A new four-paper series in The Lancet Public Health reflects a two-year collaboration among researchers at San Diego State University and the Johns Hopkins Bloomberg School of Public Health, the Global Network of Sex Work Projects (NSWP), and sex workers from diverse geographic settings. Developed through meaningful community partnership, the collection provides the most comprehensive synthesis of evidence on sex workers&#039; health in more than a decade and offers a contemporary approach to inform future research, policy and practice.</description>
                    <link>https://medicalxpress.com/news/2026-07-paper-series-broadens-sex-workers.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Jul 2026 07:20:05 EDT</pubDate>
                    <guid isPermaLink="false">news704432761</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/condoms.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>HIV progress in &#039;real danger&#039; as global funding plummets</title>
                    <description>The science has never been better, but political will has reached a new low: AIDS experts warned Monday that the fight against HIV was in real danger as funding fell by a fifth last year.</description>
                    <link>https://medicalxpress.com/news/2026-07-hiv-real-danger-global-funding.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Jul 2026 04:48:53 EDT</pubDate>
                    <guid isPermaLink="false">news704432898</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-protest-at-the-us-ca.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
